CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

CVRx, Inc.NASDAQ: CVRX

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue declines year over year

Q1 FY2026 cost of revenue of $1.89M fell 7.3% year over year, behind the -0.9% change in trailing-twelve-month cost of revenue. Sequentially, it fell 14.1% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.

Context

  • Cost of revenue amounted to 14.7% of revenue in FY2025, down 1.6 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -7.3% toward the trailing-twelve-month pace of -0.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.89M-14.1% QoQ
Last fiscal yearDec 2025
$8.31M-0.3% YoY
LTMMar 2026
$8.55M-0.9% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.3%——
1 year-0.3%——
3-year CAGR+18.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
8.31M USD
Year-over-year change
-0.3%
4-year CAGR
+22.9%

Cost of Revenue vs competitors

How CVRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -0.9% is the 7th highest of 9, against a peer median of +21.2%.
  • Cost of revenue amounts to 14.5% of revenue for CVRX, versus a peer median of 45.7%.
CVRX Competitors
Cost of Revenue for CVRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VMDViemed Healthcare, Inc.LTM Mar 2026$122.3M USD+27.2%+28.5%42.7%
CERSCerus CorporationLTM Mar 2026$101.8M USD+25.0%+8.5%45.7%
QTRXQuanterix CorporationLTM Mar 2026$80.87M USD+47.8%+7.1%55.8%
MASS908 Devices Inc.LTM Mar 2026$29.48M USD+5.6%+12.2%51.0%
NNOXNano-X Imaging Ltd.LTM Dec 2025$25.81M USD+17.4%+18.6%198.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$19.51M USD-11.2%+12.6%47.9%
SGHTSight Sciences, Inc.LTM Mar 2026$11M USD-1.8%-4.7%13.8%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$10.78M USD+27.5%+32.5%24.3%
CVRXCVRx, Inc.LTM Mar 2026$8.55M USD-0.9%+18.5%14.5%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.38M EUR——10.3%
Peer median (excluding CVRX) —+21.2%+12.4%45.7%

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.04M22.47M39.3M51.29M56.65M
Cost of Revenue3.64M5M6.26M8.33M8.31M
Gross Profit9.4M17.47M33.04M42.96M48.34M
Gross Margin72.1%77.8%84.1%83.8%85.3%
Research & Development7.5M9.95M11.63M11.13M11.13M
Selling, General & Admin27.86M50.05M64.51M91.32M88.47M
Operating Expenses35.36M60M76.14M102.45M99.61M
Depreciation & Amortization168K412K522K619K756K
EBITDA(40.6M)(40.74M)(38.73M)(54.89M)(46.74M)
EBITDA Margin-311.4%-181.3%-98.6%-107.0%-82.5%
Operating Income(25.97M)(42.53M)(43.1M)(59.49M)(51.27M)
Operating Margin-199.2%-189.3%-109.7%-116.0%-90.5%
Interest Income00000
Interest Expense2.22M165K1.8M4.4M5.83M
Other Income / Expenses(17.02M)1.21M2.05M(420K)(2.06M)
Income Before Tax(42.99M)(41.32M)(41.05M)(59.91M)(53.32M)
Pre-Tax Margin-329.8%-183.9%-104.5%-116.8%-94.1%
Income Tax Expense91K109K147K55K(18K)
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Net Margin-330.5%-184.4%-104.8%-116.9%-94.1%
EPS (Basic)(2.11)(2.02)(1.99)(2.65)(2.04)
EPS (Diluted)(2.11)(2.02)(1.99)(2.65)(2.04)
Weighted Avg Shares20.72M20.51M20.7M22.6M26.08M
Weighted Avg Shares (Diluted)20.72M20.53M20.75M22.6M26.08M

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.